{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:48:26Z","timestamp":1785757706210,"version":"3.56.0"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":66,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2024T170246"],"award-info":[{"award-number":["2024T170246"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Open Grant from the Pingyuan Laboratory","award":["2023PY-OP-0202"],"award-info":[{"award-number":["2023PY-OP-0202"]}]},{"name":"Open Project of Henan Province Engineering Research Center of Diagnosis and Treatment of Pediatric Infection and Critical Care","award":["ERC202302"],"award-info":[{"award-number":["ERC202302"]}]},{"name":"Open Project of Key Laboratory of Infection and Immunity of Anhui Higher Education Institutes","award":["I&I-2024-R01"],"award-info":[{"award-number":["I&I-2024-R01"]}]},{"name":"Open Project of Key Laboratory of Children's Disease Research in Guangxi's Colleges and Universities","award":["GXCDR202401"],"award-info":[{"award-number":["GXCDR202401"]}]},{"name":"Program for Innovative Talents in Higher Education Institutions of Henan Province","award":["25HASTIT055"],"award-info":[{"award-number":["25HASTIT055"]}]},{"name":"supported by Outstanding Youth Science Foundation of Henan Province","award":["252300421122"],"award-info":[{"award-number":["252300421122"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Microbiol"],"DOI":"10.1186\/s12866-026-05230-1","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T10:24:46Z","timestamp":1780050286000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Dysregulated myeloid-T cell immunity in refractory Mycoplasma pneumoniae pneumonia: high inflammation meets T cell suppression"],"prefix":"10.1186","volume":"26","author":[{"given":"Yanjuan","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaijing","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunbo","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genhao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouhang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuefei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"issue":"1","key":"5230_CR1","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1080\/22221751.2022.2078228","volume":"11","author":"X Wang","year":"2022","unstructured":"Wang X, Li M, Luo M, Luo Q, Kang L, Xie H, et al. Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020. Emerg Microbes Infect. 2022;11(1):1508\u201317.","journal-title":"Emerg Microbes Infect"},{"issue":"9","key":"5230_CR2","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJMoa1405870","volume":"372","author":"S Jain","year":"2015","unstructured":"Jain S, Williams DJ, Arnold SR, Ampofo K, Bramley AM, Reed C, et al. Community-acquired pneumonia requiring hospitalization among U.S. children. N Engl J Med. 2015;372(9):835\u201345.","journal-title":"N Engl J Med"},{"key":"5230_CR3","doi-asserted-by":"publisher","first-page":"5002521","DOI":"10.1155\/2024\/5002521","volume":"2024","author":"X Kan","year":"2024","unstructured":"Kan X, Wu Y, Zhang X, Zeng Z, Lou C, Wu L, et al. Palm Multidiagnostic of Mycoplasma pneumoniae, Chlamydia pneumoniae, Haemophilus influenzae, and Streptococcus pneumoniae Using One-Tube CRISPR\/Cas12a. Transbound Emerg Dis. 2024;2024:5002521.","journal-title":"Transbound Emerg Dis"},{"issue":"1","key":"5230_CR4","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1186\/s12931-024-02892-1","volume":"25","author":"D Wei","year":"2024","unstructured":"Wei D, Zhao Y, Zhang T, Xu Y, Guo W. The role of LDH and ferritin levels as biomarkers for corticosteroid dosage in children with refractory Mycoplasma pneumoniae pneumonia. Respir Res. 2024;25(1):266.","journal-title":"Respir Res"},{"issue":"4","key":"5230_CR5","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1007\/s12519-018-0162-6","volume":"14","author":"X Wang","year":"2018","unstructured":"Wang X, Zhong LJ, Chen ZM, Zhou YL, Ye B, Zhang YY. Necrotizing pneumonia caused by refractory Mycoplasma pneumonia pneumonia in children. World J Pediatr. 2018;14(4):344\u20139.","journal-title":"World J Pediatr"},{"key":"5230_CR6","doi-asserted-by":"crossref","unstructured":"Tong L, Huang S, Zheng C, Zhang Y, Chen Z. Refractory Mycoplasma pneumoniae Pneumonia in Children: Early Recognition and Management. J Clin Med. 2022;11(10):2824.","DOI":"10.3390\/jcm11102824"},{"issue":"1","key":"5230_CR7","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1186\/s13052-022-01376-6","volume":"48","author":"XW Zhan","year":"2022","unstructured":"Zhan XW, Deng LP, Wang ZY, Zhang J, Wang MZ, Li SJ. Correlation between Mycoplasma pneumoniae drug resistance and clinical characteristics in bronchoalveolar lavage fluid of children with refractory Mycoplasma pneumoniae pneumonia. Ital J Pediatr. 2022;48(1):190.","journal-title":"Ital J Pediatr"},{"key":"5230_CR8","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1186\/1471-2334-12-126","volume":"12","author":"N Miyashita","year":"2012","unstructured":"Miyashita N, Kawai Y, Akaike H, Ouchi K, Hayashi T, Kurihara T, et al. Macrolide-resistant Mycoplasma pneumoniae in adolescents with community-acquired pneumonia. BMC Infect Dis. 2012;12:126.","journal-title":"BMC Infect Dis"},{"key":"5230_CR9","doi-asserted-by":"publisher","first-page":"37037","DOI":"10.1038\/srep37037","volume":"6","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Mei S, Zhou Y, Huang M, Dong G, Chen Z. Cytokines as the good predictors of refractory Mycoplasma pneumoniae pneumonia in school-aged children. Sci Rep. 2016;6:37037.","journal-title":"Sci Rep"},{"issue":"1","key":"5230_CR10","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s12931-019-1152-5","volume":"20","author":"YJ Choi","year":"2019","unstructured":"Choi YJ, Jeon JH, Oh JW. Critical combination of initial markers for predicting refractory Mycoplasma pneumoniae pneumonia in children: a case control study. Respir Res. 2019;20(1):193.","journal-title":"Respir Res"},{"key":"5230_CR11","unstructured":"Guidelines for Diagnosis and Treatment of Mycoplasma pneumoniae Pneumonia in Children. (2023 Edition) https:\/\/www.gov.cn\/zhengce\/zhengceku\/2023-02\/16\/content_5741770.htm"},{"key":"5230_CR12","unstructured":"Intensivists CSoP. Clinical practice guidelines for bronchoalveolar lavage in Chinese children (2024). Chin J Contemp Pediatr. 2024;26(1):1\u201313."},{"key":"5230_CR13","doi-asserted-by":"publisher","first-page":"1302702","DOI":"10.3389\/fimmu.2023.1302702","volume":"14","author":"D Li","year":"2023","unstructured":"Li D, Gu H, Chen L, Wu R, Jiang Y, Huang X, et al. Neutrophil-to-lymphocyte ratio as a predictor of poor outcomes of Mycoplasma pneumoniae pneumonia. Front Immunol. 2023;14:1302702.","journal-title":"Front Immunol"},{"key":"5230_CR14","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.ijid.2014.07.020","volume":"29","author":"M Wang","year":"2014","unstructured":"Wang M, Wang Y, Yan Y, Zhu C, Huang L, Shao X, et al. Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children. Int J Infect Dis. 2014;29:18\u201323.","journal-title":"Int J Infect Dis"},{"issue":"1","key":"5230_CR15","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s10020-019-0105-2","volume":"25","author":"G Li","year":"2019","unstructured":"Li G, Fan L, Wang Y, Huang L, Wang M, Zhu C, et al. High co-expression of TNF-alpha and CARDS toxin is a good predictor for refractory Mycoplasma pneumoniae pneumonia. Mol Med. 2019;25(1):38.","journal-title":"Mol Med"},{"issue":"1","key":"5230_CR16","doi-asserted-by":"publisher","first-page":"4304","DOI":"10.1038\/s41598-021-83654-7","volume":"11","author":"Y Cai","year":"2021","unstructured":"Cai Y, Liu J, Yang H, Chen T, Yu Q, Chen J, et al. Correlation between early features and prognosis of symptomatic COVID-19 discharged patients in Hunan, China. Sci Rep. 2021;11(1):4304.","journal-title":"Sci Rep"},{"issue":"3","key":"5230_CR17","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1128\/CMR.00114-16","volume":"30","author":"KB Waites","year":"2017","unstructured":"Waites KB, Xiao L, Liu Y, Balish MF, Atkinson TP. Mycoplasma pneumoniae from the Respiratory Tract and Beyond. Clin Microbiol Rev. 2017;30(3):747\u2013809.","journal-title":"Clin Microbiol Rev"},{"issue":"15","key":"5230_CR18","doi-asserted-by":"publisher","first-page":"e2004433","DOI":"10.1002\/advs.202004433","volume":"8","author":"C Liu","year":"2021","unstructured":"Liu C, Chu D, Kalantar-Zadeh K, George J, Young HA, Liu G. Cytokines: From Clinical Significance to Quantification. Adv Sci (Weinh). 2021;8(15):e2004433.","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"5230_CR19","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1186\/s13052-023-01528-2","volume":"49","author":"J Zhu","year":"2023","unstructured":"Zhu J, Liu X, Zhan X, Wang M, Zhang Y, Na L, et al. Predictive value of chemokines (CCL 2) in bronchoalveolar lavage fluid for refractory mycoplasma pneumonia in children. Ital J Pediatr. 2023;49(1):125.","journal-title":"Ital J Pediatr"},{"key":"5230_CR20","doi-asserted-by":"crossref","unstructured":"Huang F, Fan H, Yang D, Zhang J, Shi T, Zhang D et al. Ribosomal RNA\u2013depleted RNA sequencing reveals the pathogenesis of refractory Mycoplasma pneumoniae pneumonia in children. Mol Med Rep. 2021;24(5):761.","DOI":"10.3892\/mmr.2021.12401"},{"key":"5230_CR21","doi-asserted-by":"crossref","unstructured":"Zhang Y, Zhou Y, Li S, Yang D, Wu X, Chen Z. The Clinical Characteristics and Predictors of Refractory Mycoplasma pneumoniae Pneumonia in Children. PLoS ONE. 2016;11(5):e0156465.","DOI":"10.1371\/journal.pone.0156465"},{"issue":"3","key":"5230_CR22","doi-asserted-by":"publisher","first-page":"396","DOI":"10.21037\/tp-23-86","volume":"12","author":"WH Zhang","year":"2023","unstructured":"Zhang WH, Zhou MP, Zou YY, Chen JW, Wang T, Huang L, et al. The predictive values of soluble B7-DC in children with refractory mycoplasma pneumoniae pneumonia. Transl Pediatr. 2023;12(3):396\u2013404.","journal-title":"Transl Pediatr"},{"issue":"8","key":"5230_CR23","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","volume":"13","author":"DA Vignali","year":"2012","unstructured":"Vignali DA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol. 2012;13(8):722\u20138.","journal-title":"Nat Immunol"},{"issue":"3","key":"5230_CR24","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1080\/14712598.2020.1714027","volume":"20","author":"A Moran","year":"2020","unstructured":"Moran A, Pavord ID. Anti-IL-4\/IL-13 for the treatment of asthma: the story so far. Expert Opin Biol Ther. 2020;20(3):283\u201394.","journal-title":"Expert Opin Biol Ther"},{"key":"5230_CR25","doi-asserted-by":"publisher","first-page":"888","DOI":"10.3389\/fimmu.2018.00888","volume":"9","author":"IS Junttila","year":"2018","unstructured":"Junttila IS. Tuning the Cytokine Responses: An Update on Interleukin (IL)-4 and IL-13 Receptor Complexes. Front Immunol. 2018;9:888.","journal-title":"Front Immunol"},{"issue":"12","key":"5230_CR26","doi-asserted-by":"publisher","first-page":"1584","DOI":"10.1038\/s41590-019-0479-x","volume":"20","author":"JT Barata","year":"2019","unstructured":"Barata JT, Durum SK, Seddon B. Flip the coin: IL-7 and IL-7R in health and disease. Nat Immunol. 2019;20(12):1584\u201393.","journal-title":"Nat Immunol"},{"issue":"1","key":"5230_CR27","doi-asserted-by":"publisher","first-page":"6881","DOI":"10.1038\/s41467-022-34660-4","volume":"13","author":"L Xu","year":"2022","unstructured":"Xu L, Wei C, Chen Y, Wu Y, Shou X, Chen W, et al. IL-33 induces thymic involution-associated naive T cell aging and impairs host control of severe infection. Nat Commun. 2022;13(1):6881.","journal-title":"Nat Commun"},{"issue":"5","key":"5230_CR28","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1038\/s41590-024-01804-1","volume":"25","author":"N Fortelny","year":"2024","unstructured":"Fortelny N, Farlik M, Fife V, Gorki AD, Lassnig C, Maurer B, et al. JAK-STAT signaling maintains homeostasis in T cells and macrophages. Nat Immunol. 2024;25(5):847\u201359.","journal-title":"Nat Immunol"},{"key":"5230_CR29","doi-asserted-by":"publisher","first-page":"2412","DOI":"10.3389\/fimmu.2018.02412","volume":"9","author":"C Pedros","year":"2018","unstructured":"Pedros C, Altman A, Kong KF. Role of TRAFs in Signaling Pathways Controlling T Follicular Helper Cell Differentiation and T Cell-Dependent Antibody Responses. Front Immunol. 2018;9:2412.","journal-title":"Front Immunol"},{"issue":"1","key":"5230_CR30","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s12964-017-0177-y","volume":"15","author":"F Seif","year":"2017","unstructured":"Seif F, Khoshmirsafa M, Aazami H, Mohsenzadegan M, Sedighi G, Bahar M. The role of JAK-STAT signaling pathway and its regulators in the fate of T helper cells. Cell Commun Signal. 2017;15(1):23.","journal-title":"Cell Commun Signal"},{"key":"5230_CR31","doi-asserted-by":"publisher","first-page":"106362","DOI":"10.1016\/j.phrs.2022.106362","volume":"183","author":"R Roskoski","year":"2022","unstructured":"Roskoski R. Jr. Janus kinase (JAK) inhibitors in the treatment of neoplastic and inflammatory disorders. Pharmacol Res. 2022;183:106362.","journal-title":"Pharmacol Res"},{"issue":"1","key":"5230_CR32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1182\/blood.V99.1.224","volume":"99","author":"C Bovolenta","year":"2002","unstructured":"Bovolenta C, Pilotti E, Mauri M, Turci M, Ciancianaini P, Fisicaro P, et al. Human T-cell leukemia virus type 2 induces survival and proliferation of CD34(+) TF-1 cells through activation of STAT1 and STAT5 by secretion of interferon-gamma and granulocyte macrophage-colony-stimulating factor. Blood. 2002;99(1):224\u201331.","journal-title":"Blood"},{"issue":"1","key":"5230_CR33","doi-asserted-by":"publisher","first-page":"280","DOI":"10.4049\/jimmunol.178.1.280","volume":"178","author":"MA Burchill","year":"2007","unstructured":"Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA. IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3\u2009+\u2009regulatory T cells. J Immunol. 2007;178(1):280\u201390.","journal-title":"J Immunol"},{"key":"5230_CR34","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.phrs.2016.07.038","volume":"111","author":"R Roskoski","year":"2016","unstructured":"Roskoski R. Jr. Janus kinase (JAK) inhibitors in the treatment of inflammatory and neoplastic diseases. Pharmacol Res. 2016;111:784\u2013803.","journal-title":"Pharmacol Res"}],"container-title":["BMC Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12866-026-05230-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12866-026-05230-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T11:24:32Z","timestamp":1785756272000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12866-026-05230-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5230"],"URL":"https:\/\/doi.org\/10.1186\/s12866-026-05230-1","relation":{},"ISSN":["1471-2180"],"issn-type":[{"value":"1471-2180","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"16 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This study was approved by the Ethics Committee of Zhengzhou University (No. ZZUIRB2024-204). Written informed consent was obtained from all participants and their parent\/legal guardian included in the study. All experiments and analyses involving human data and samples were conducted in accordance with the Helsinki Declaration.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"Not Applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"<b>Declarations<\/b>"}}],"article-number":"687"}}